Advances of Melatonin-Based Therapies in the Treatment of Disturbed Sleep and Mood

Research output: Chapter in Book/Report/Conference proceedingChapter (Book)Other

Abstract

Melatonin and melatonin agonists offer novel treatments for sleep and mood disorders, particularly where circadian misalignment is also present. The therapies offer both phase-shifting and sleep-promoting effects and have shown potential to treat advanced and delayed sleep-wake phase disorder, non-24-h sleep-wake cycle, jetlag, shift work disorder, insomnia, seasonal affective disorder and major depressive disorder.
Original languageEnglish
Title of host publicationHandbook of Experimental Pharmacology
Place of PublicationBerlin
PublisherSpringer
Number of pages15
DOIs
Publication statusAccepted/In press - 24 May 2019

Cite this

@inbook{2b9e009a69ed4af5914e934e15699e52,
title = "Advances of Melatonin-Based Therapies in the Treatment of Disturbed Sleep and Mood",
abstract = "Melatonin and melatonin agonists offer novel treatments for sleep and mood disorders, particularly where circadian misalignment is also present. The therapies offer both phase-shifting and sleep-promoting effects and have shown potential to treat advanced and delayed sleep-wake phase disorder, non-24-h sleep-wake cycle, jetlag, shift work disorder, insomnia, seasonal affective disorder and major depressive disorder.",
author = "Megan Alston and Cain, {Sean W.} and Rajaratnam, {Shantha M.W.}",
year = "2019",
month = "5",
day = "24",
doi = "10.1007/164_2018_139",
language = "English",
booktitle = "Handbook of Experimental Pharmacology",
publisher = "Springer",

}

Advances of Melatonin-Based Therapies in the Treatment of Disturbed Sleep and Mood. / Alston, Megan; Cain, Sean W.; Rajaratnam, Shantha M.W.

Handbook of Experimental Pharmacology. Berlin : Springer, 2019.

Research output: Chapter in Book/Report/Conference proceedingChapter (Book)Other

TY - CHAP

T1 - Advances of Melatonin-Based Therapies in the Treatment of Disturbed Sleep and Mood

AU - Alston, Megan

AU - Cain, Sean W.

AU - Rajaratnam, Shantha M.W.

PY - 2019/5/24

Y1 - 2019/5/24

N2 - Melatonin and melatonin agonists offer novel treatments for sleep and mood disorders, particularly where circadian misalignment is also present. The therapies offer both phase-shifting and sleep-promoting effects and have shown potential to treat advanced and delayed sleep-wake phase disorder, non-24-h sleep-wake cycle, jetlag, shift work disorder, insomnia, seasonal affective disorder and major depressive disorder.

AB - Melatonin and melatonin agonists offer novel treatments for sleep and mood disorders, particularly where circadian misalignment is also present. The therapies offer both phase-shifting and sleep-promoting effects and have shown potential to treat advanced and delayed sleep-wake phase disorder, non-24-h sleep-wake cycle, jetlag, shift work disorder, insomnia, seasonal affective disorder and major depressive disorder.

U2 - 10.1007/164_2018_139

DO - 10.1007/164_2018_139

M3 - Chapter (Book)

BT - Handbook of Experimental Pharmacology

PB - Springer

CY - Berlin

ER -